Celldex Therapeutics, Inc

CLDXNASDAQ • USD
27.98 USD
↘ 0.61 (2.13%)🟢LIVE (AS OF 02:24 PM EST)
🟢Market: OPEN

Shares of Celldex Therapeutics, Inc (CLDX) are trading at $27.98. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$28.77
High?$29.73
Low?$27.51
Prev. Close?$28.59
Volume?208.2K
Avg. Volume?1.1M
VWAP?$28.01
Rel. Volume?0.18x
Bid / Ask
Bid?$27.40 × 100
Ask?$27.94 × 400
Spread?$0.54
Midpoint?$27.67
Valuation & Ratios
Market Cap?2.2B
Shares Out?78.6M
Float?74.0M
Float %?94.2%
P/E Ratio?N/A
P/B Ratio?3.46
EPS?-$3.93
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Employees
198
Market Cap
2.3B
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed
1986-05-15
Address
53 FRONTAGE ROAD
HAMPTON, NJ 08827
Phone: 908-200-7500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
28
Piotroski F-Score?0/9Weak
Altman Z-Score?14.21Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?13.43%High
Short Interest?9.9M
Days to Cover?10.4
Free Float74.0M
Avg Daily Volume959.8K
Settlement Date2026-10-30
Financial Health
Current Ratio?10.97Strong
Quick Ratio?10.97Strong
Cash Ratio?0.45Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
49
3.46FAIR▾
P/S?
Peers
100
S&P
3
14,212.68HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.7CHEAP▾
EV/Sales?
Peers
100
S&P
3
14,042.09HIGH▾
Returns & Efficiency
ROE?
S&P
3
-47.6%WEAK▾
ROA?
S&P
3
-42.8%WEAK▾
Cash Flow & Enterprise
FCF?$-259739000
Enterprise Value?$2.2B
Fundamentals ratios updated end of day